These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 11967807

  • 1. Combination of non-hypotensive doses of valsartan and enalapril improves survival of spontaneously hypertensive rats with endothelial dysfunction.
    de Gasparo M, Hess P, Nuesslein-Hildesheim B, Bruneval P, Clozel JP.
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):151-8. PubMed ID: 11967807
    [Abstract] [Full Text] [Related]

  • 2. Effect of simvastatin given alone and in combination with valsartan or enalapril on blood pressure and the structure of mesenteric resistance arteries and the basilar artery in the genetically hypertensive rat model.
    Ledingham JM, Laverty R.
    Clin Exp Pharmacol Physiol; 2005 Jun; 32(1-2):76-85. PubMed ID: 15730439
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 2nd communication: valsartan prevents end-organ damage in spontaneously hypertensive stroke-prone rats during 1-year treatment.
    Kometani M, Hayashi N, Yamamoto S, Nakao K, Inukai T.
    Arzneimittelforschung; 1997 May; 47(5):613-9. PubMed ID: 9205774
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 1st communication: antihypertensive effects of valsartan in hypertensive models.
    Yamamoto S, Hayashi N, Kometani M, Nakao K, Inukai T.
    Arzneimittelforschung; 1997 May; 47(5):604-12. PubMed ID: 9205773
    [Abstract] [Full Text] [Related]

  • 5. Effect of combination of valsartan with benazepril on blood pressure and left ventricular hypertrophy in SHR.
    Ke YS, Cao H, Yang T.
    Acta Pharmacol Sin; 2000 Nov; 21(11):1043-7. PubMed ID: 11501062
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 7. Combination of low-dose valsartan and enalapril improves endothelial dysfunction and coronary reserve in Nomega-nitro-L-arginine methyl ester-treated spontaneously hypertensive rats.
    de Gasparo M, Hess P, Clozel M, Persohn E, Roman D, Germann PG, Clozel JP, Webb RL.
    J Cardiovasc Pharmacol; 2002 Nov; 40(5):789-800. PubMed ID: 12409988
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
    Lassila M, Davis BJ, Allen TJ, Burrell LM, Cooper ME, Cao Z.
    Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675
    [Abstract] [Full Text] [Related]

  • 10. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
    Ferri C, Croce G, Desideri G.
    Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
    [Abstract] [Full Text] [Related]

  • 11. Combined angiotensin II AT1-receptor blockade and angiotensin I-converting enzyme inhibition on survival and cardiac remodeling in chronic heart failure in rats.
    Richer C, Fornes P, Domergue V, De Gasparo M, Giudicelli JF.
    J Card Fail; 2001 Sep; 7(3):269-76. PubMed ID: 11561229
    [Abstract] [Full Text] [Related]

  • 12. Strong suppression of the renin-angiotensin system has a renal-protective effect in hypertensive patients: high-dose ARB with ACE inhibitor (Hawaii) study.
    Ohishi M, Takeya Y, Tatara Y, Yamamoto K, Onishi M, Maekawa Y, Kamide K, Rakugi H.
    Hypertens Res; 2010 Nov; 33(11):1150-4. PubMed ID: 20703230
    [Abstract] [Full Text] [Related]

  • 13. Effects of glitazones on blood pressure and vascular structure in mesenteric resistance arteries and basilar artery from genetically hypertensive rats.
    Ledingham JM, Laverty R.
    Clin Exp Pharmacol Physiol; 2005 Nov; 32(11):919-25. PubMed ID: 16405447
    [Abstract] [Full Text] [Related]

  • 14. Anti-inflammatory effects of AT1 receptor blockade provide end-organ protection in stroke-prone rats independently from blood pressure fall.
    Sironi L, Gelosa P, Guerrini U, Banfi C, Crippa V, Brioschi M, Gianazza E, Nobili E, Gianella A, de Gasparo M, Tremoli E.
    J Pharmacol Exp Ther; 2004 Dec; 311(3):989-95. PubMed ID: 15302895
    [Abstract] [Full Text] [Related]

  • 15. Beneficial effects of combination of valsartan and amlodipine on salt-induced brain injury in hypertensive rats.
    Dong YF, Kataoka K, Tokutomi Y, Nako H, Nakamura T, Toyama K, Sueta D, Koibuchi N, Yamamoto E, Ogawa H, Kim-Mitsuyama S.
    J Pharmacol Exp Ther; 2011 Nov; 339(2):358-66. PubMed ID: 21807884
    [Abstract] [Full Text] [Related]

  • 16. Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.
    Pu Q, Brassard P, Javeshghani DM, Iglarz M, Webb RL, Amiri F, Schiffrin EL.
    J Hypertens; 2008 Feb; 26(2):322-33. PubMed ID: 18192847
    [Abstract] [Full Text] [Related]

  • 17. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J, Ortiz MC, O'Valle F, Alcaraz A, Navarro EG, Vargas F, Evangelista S, Atucha NM.
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [Abstract] [Full Text] [Related]

  • 18. Basilar artery remodelling in the genetically hypertensive rat: effects of nitric oxide synthase inhibition and treatment with valsartan and enalapril.
    Ledingham JM, Laverty R.
    Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):642-6. PubMed ID: 10901398
    [Abstract] [Full Text] [Related]

  • 19. Cardiac mitochondrial function and tissue remodelling are improved by a non-antihypertensive dose of enalapril in spontaneously hypertensive rats.
    Piotrkowski B, Koch OR, De Cavanagh EM, Fraga CG.
    Free Radic Res; 2009 Apr; 43(4):390-9. PubMed ID: 19296328
    [Abstract] [Full Text] [Related]

  • 20. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial.
    Hermida RC, Ayala DE, Khder Y, Calvo C.
    Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.